Teradyne CEO exercises 2,072 options; 95,624.995 shares held
Teradyne (TER) reported an insider equity transaction by its President and CEO, who is also a director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Teradyne (TER) reported an insider equity transaction by its President and CEO, who is also a director. On November 5, 2025, the executive exercised a stock option for 2,072 shares at an exercise price of $36.75 (code M).
To cover the option exercise price and associated tax withholding, the issuer withheld 1,224 shares at a price of $177.05 (code F), as noted in the footnotes. Following these transactions, the reporting person beneficially owned 95,624.995 shares, held directly.
The option referenced vested 25% per year over four years beginning January 25, 2020.
Insights
Routine Form 4: option exercise with share withholding; neutral impact.
The Teradyne President and CEO exercised an option for 2,072 shares at $36.75 on November 5, 2025 (code M). The company withheld 1,224 shares at $177.05 (code F) to satisfy the exercise price and tax obligations, per the footnote.
After the transactions, beneficial ownership stood at 95,624.995 shares, held directly. The option originally vested in four annual installments starting January 25, 2020. This filing documents standard equity compensation activity; cash-flow treatment beyond share withholding is not detailed in the excerpt.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 2,072 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,072 | $36.75 | $76K |
| Exercise Price or Tax Liability | Common Stock | 1,224 | $177.05 | $217K |
Footnotes (2)
- F1. Shares withheld by the Issuer to pay the exercise price of the stock option exercise reported in this Form 4 and to satisfy the Reporting Person's tax withholding obligations in connection with such exercise.
- F2. The option vested 25% per year over four years beginning on January 25, 2020, the first anniversary of its grant.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did TER's CEO report on Form 4?
What was the option’s vesting schedule?
What do transaction codes M and F mean on the Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.